Dr Colm Henry provided a high-level overview on a number of areas, noting the following;
Covid Vaccination Programme - Over 3.86 million people have now received the first dose or single dose of their vaccine and over 3.80 million have received their second dose or single dose (as of 5th December). The Booster operational plan is based on cohort priorities and eligibility. Ca. 27,500 booster doses have been administered to residents in Long Term Residential Care facilities with those residents over 65 substantially completed. Healthcare Workers are two thirds complete with Ca. 209,300 vaccinated
Omicron Variant (as of 9th December)-Significant concern has been raised internationally following the recent detection of the variant B.1.1.529. Cases of B.1.1.529 have been confirmed in a number of countries/regions internationally including South Africa, Botswana, Hong Kong and Israel.
Epidemiology -One hundred and nine COVID-19 cases are currently identified as confirmed, probable or possible (PUI) Omicron cases as a result of S-gene target failure (SGTF) results since October on the TaqPath PCR assay (a type of PCR test), being a contact of a confirmed case or having recently travelled outside Ireland or having contact with a case who has recently travelled.
The CCO also provided the Committee with a briefing on the establishment of National COVID-19 Therapeutics Advisory Group, he informed the Committee that the purpose of the group is to provide clinical advice and recommendations to the CCO on the use of all existing and emerging approved COVID-19 therapeutic medications. The group will support implementation by developing clear guidance and providing clinical leadership to support care pathways and equitable access based on clinical need and prioritisation where therapeutic drug supply is limited.
With regards to the impact of 4th Wave, the CCO said that despite high vaccination uptake, the roll out of a booster programme to at-risk population sub-groups and the maintenance of several non-pharmaceutical interventions and case numbers are continuing to rise. Rising case numbers are translating into increasing harm and are showing an increase in hospital and ICU admissions in both unvaccinated and vaccinated individuals. He noted that the latest revised modelling from the National Public Health Emergency Team are showing positivity in terms of the peak cases and hospitalisation.
However, he highlighted there remains no certainty regarding the disease trajectory and case numbers continue to rise, the system will be under sustained pressure in the weeks to come.
The Committee were also given an overview on the secondary impact of COVID on a number of services. With regards to the National Screening Service the CCO noted that NSS are continuing to deliver screening across all four programmes with reduced capacity.
Breast Check is running at approximately 80% capacity, however increased Covid infections in the community may impact hospital capacity and this is being monitored. Cervical Check has screened 280,787 women between January to October 2021 which is 17% above the target of 240,000. Bowel Screen provisional number of clients who have completed a satisfactory FIT test between Jan to Oct 2021 is 77,913 which is above the revised target by 5,413 (7.5%) and DRS 2-yearly screening pathway is in place eight months and to date, of those screened approximately 85% will remain on the 2-yearly pathway.
Breast Check, 15,994 (provisional data) participants were screened from 1st November to 30th November;
Cervical Check has now issued all reminder letters that were paused in 2020 and the letter release strategy is complete. The programme is operating normally and as a result of COVID-19, the status of the 14 Bowel Screen units on 1st of December 2021 is that all Bowel Screen units are scheduling cases at reduced capacity.
The Committee were informed that the National Cancer Control Programme (NCRI) 2021 Annual Report was published last week.
The Committee held a detailed discussion on the impact of Covid on Healthcare staff and the pressures and challenges that they are continually working under. The Employee Assistant Programme (EAP) has continued to provide staff counselling, psychosocial support and manager consultations. In addition, a new national EAP phone line has been set up to provide easier access. The service has also increased the number of EAP counsellors available nationwide and launched the EAP Inspire Support Hub which gives access to a range of high-quality wellbeing resources that can be accessed 24/7.